14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $18.05 $25.50 Thursday, 2nd May 2024 PHVS stock ended at $23.53. This is 4.23% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 8.56% from a day low at $23.49 to a day high of $25.50.
90 days $18.05 $33.00
52 weeks $7.93 $33.00

Historical Pharvaris B.V. prices

Date Open High Low Close Volume
Dec 07, 2023 $26.08 $26.57 $25.00 $25.42 506 208
Dec 06, 2023 $26.87 $29.80 $24.20 $24.75 2 227 154
Dec 05, 2023 $17.96 $20.95 $17.80 $20.95 24 993
Dec 04, 2023 $18.62 $18.62 $18.06 $18.22 17 675
Dec 01, 2023 $17.20 $18.90 $16.81 $18.59 86 318
Nov 30, 2023 $17.67 $17.67 $16.87 $17.21 6 172
Nov 29, 2023 $17.50 $17.65 $17.31 $17.31 3 606
Nov 28, 2023 $17.70 $17.77 $17.06 $17.65 39 911
Nov 27, 2023 $16.94 $17.50 $16.80 $17.20 13 694
Nov 24, 2023 $16.43 $16.94 $16.38 $16.94 2 541
Nov 22, 2023 $16.03 $16.35 $15.55 $16.12 10 385
Nov 21, 2023 $15.01 $16.23 $15.00 $15.52 8 041
Nov 20, 2023 $15.83 $16.15 $15.00 $15.20 642 059
Nov 17, 2023 $15.60 $16.49 $15.28 $16.15 79 798
Nov 16, 2023 $16.40 $16.77 $15.60 $15.61 71 382
Nov 15, 2023 $17.65 $18.31 $16.40 $16.40 154 632
Nov 14, 2023 $17.35 $19.00 $17.23 $18.53 40 143
Nov 13, 2023 $17.30 $18.32 $16.83 $16.85 10 250
Nov 10, 2023 $16.45 $19.38 $16.00 $17.60 18 668
Nov 09, 2023 $17.00 $17.00 $16.29 $16.75 5 120
Nov 08, 2023 $17.36 $18.00 $16.93 $17.20 20 941
Nov 07, 2023 $17.17 $17.37 $16.91 $17.37 25 187
Nov 06, 2023 $18.43 $18.43 $16.97 $16.97 15 795
Nov 03, 2023 $17.48 $18.48 $17.17 $18.48 14 351
Nov 02, 2023 $17.00 $17.68 $16.91 $17.18 127 439
Click to get the best stock tips daily for free!

About Pharvaris B.V.

Pharvaris B.V. Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical ... PHVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT